Physician profile
David Dc Smith
NPI 1609091628
$477.10
in general payments reported to CMS, 2019-2025
10 companies · $85.02 in 2025
The $85.02 reported for 2025 was more than what a typical Rehabilitation (Chiropractor) provider received nationally (typical 2025 total: $25.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.46 · 2020: $37.85 · 2021: $55.32 · 2022: $54.77 · 2023: $132 · 2024: $64.91 · 2025: $85.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $106.95 | 2023-2025 | Trintellix |
| Abbvie INC. | $105.92 | 2023-2025 | Ubrelvy, Vraylar, Qulipta |
| Amarin Pharma, INC. | $80.24 | 2021-2022 | |
| Genentech USA, INC. | $72.95 | 2019-2020 | |
| Dexcom, INC. | $37.54 | 2023 | Dexcom G6 Transmitter |
| Kaleo, INC. | $17.75 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.54 | 2023 | Quviviq |
| Lilly USA, LLC | $14.75 | 2025 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.36 | 2019 | |
| Seqirus USA INC | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.